Examining how targeted cancer therapies are used in diverse populations
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
['FUNDING_R37'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11066438
This study is looking at how well targeted therapies work for people with advanced cancers like lung cancer, melanoma, and genitourinary cancer, and it aims to understand if everyone has the same chance to get these important treatments.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11066438 on ClinicalTrials.gov |
What this research studies
This research investigates the use of targeted therapies, such as molecularly targeted kinase inhibitors and immune checkpoint inhibitors, in patients with metastatic cancers. It aims to understand how these therapies are utilized across different populations, particularly focusing on factors that may affect access and delivery. By analyzing data from a diverse group of 2,240 patients diagnosed with metastatic non-small cell lung cancer, genitourinary cancer, and melanoma, the study seeks to identify patterns and disparities in treatment. The findings could help inform strategies to improve equitable access to these potentially life-saving therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with metastatic non-small cell lung cancer, genitourinary cancer, or melanoma.
Not a fit: Patients with early-stage cancers or those not diagnosed with the specified metastatic cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective cancer treatments for diverse patient populations.
How similar studies have performed: Previous research has shown that understanding treatment patterns can lead to improved healthcare delivery, indicating potential success for this approach.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VEENSTRA, CHRISTINE — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: VEENSTRA, CHRISTINE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: cancer care, Cancer Control, Cancer Control Science